362 related articles for article (PubMed ID: 27283830)
21. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
22. Development of Amorphous Solid Dispersion Sustained-Release Formulations with Polymer Composite Matrix-Regulated Stable Release Plateaus.
Chen L; Hu E; Shen P; Qian S; Heng W; Zhang J; Gao Y; Wei Y
Pharm Res; 2024 Jun; 41(6):1233-1245. PubMed ID: 38744732
[TBL] [Abstract][Full Text] [Related]
23. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
24. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
25. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
26. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
27. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
28. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
29. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
30. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
[TBL] [Abstract][Full Text] [Related]
31. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
[TBL] [Abstract][Full Text] [Related]
32. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
Wlodarski K; Tajber L; Sawicki W
Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
[TBL] [Abstract][Full Text] [Related]
34. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
Wlodarski K; Sawicki W; Kozyra A; Tajber L
Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
[TBL] [Abstract][Full Text] [Related]
35. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
[TBL] [Abstract][Full Text] [Related]
36. Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics.
Vasanthavada M; Tong WQ; Joshi Y; Kislalioglu MS
Pharm Res; 2005 Mar; 22(3):440-8. PubMed ID: 15835750
[TBL] [Abstract][Full Text] [Related]
37. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
Meng F; Trivino A; Prasad D; Chauhan H
Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
39. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
Marsac PJ; Shamblin SL; Taylor LS
Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
[TBL] [Abstract][Full Text] [Related]
40. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
Marsac PJ; Li T; Taylor LS
Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
